When 16. January 2024 – 19. January 2024 Where Miami, USA What -> Event Website Munich (DE) / Miami (US) – Hypertrust is pleased to announce the participation of our team in the upcoming Advanced Therapies Week at Miami Beach Convention Center from January 16th to 19th, 2024. According to the organizer the… Continue reading Hypertrust is attending the Advanced Therapies Week in Miami 2024
Munich/Saudi-Arabia (DE/KSA), December 11th, 2023 We are happy to announce a groundbreaking development in the realm of personalized therapies. Hypertrust is proud to share that we have entered into a Memorandum of Understanding (MOU) with Tamer Healthcare, paving the way for a remarkable leap in the infrastructure supporting Cell & Gene Therapies in the Kingdom… Continue reading Hypertrust joins forces with Tamer Healthcare in a groundbreaking MOU
Munich (DE), November 5th, 2023 We’re excited to share that Elixum, our parent company, has received the prestigious Red Dot Design Award for its outstanding UX/UI design. The Red Dot Design Award is a globally recognized symbol that honors exceptional design quality and innovation across various industries. We are particularly pleased with this award… Continue reading ATMP Orchestration Solution Hypertrust X-Chain Runs On Award-Winning UX/UI Design
Munich (DE), October 5th, 2023 Hypertrust Patient Data Care GmbH (HPDC) today announced its transition into a subsidiary of Elixum GmbH an innovative provider of next-generation supply chain planning . As part of these changes, HPDC has been renamed Hypertrust GmbH. The changes will have no impact on Hypertrust customers and partners. This strategic… Continue reading Hypertrust Patient Data Care Becomes Part of Elixum GmbH and Transforms into Hypertrust
When 30. October 2023 Where London (LON), UK What -> Event Website Munich (DE)/ London (UK) – The Gartner Supply Chain Planning Summit takes places in London from October, 29 to October, 31 2023. It’s the event for supply chain planning leaders, whose each day seems more challenging as network complexity, demand volatility, and supply… Continue reading Tigen‘s Journey Towards Resilient Supply Chain Orchestration
If we want to increase the chances of survival in various diseases today, such as cancer, heart disease and diabetes, therapeutic approaches should be tailored as precisely as possible to the individual patient. Personalized cell and gene therapies make this possible but are difficult to realize due to the expenses in supply chain management. The… Continue reading Whitepaper: Why is Supply Chain Orchestration in Cell & Gene Therapies so important?
When 29. August 2023 Where Boston, US What -> Event Website Munich (DE) / Boston (US) – the event year continues. Next up, we will be in Boston at the end of August for the 8th CAR-TCR Summit. It is the world’s preeminent, industry-leading and comprehensive forum uniting the global cell therapy community across a… Continue reading Global Cell Therapy Community Gathers at 8th CAR-TCR Summit
Munich (DE) – Personalized cell and gene therapies are emerging capabilities that are transforming patient care as we know it. In the following joint Whitepaper with Dell and CellPoint, you can learn more about Personalized Cell and Gene Therapy Orchestration and its implications on logistical processes. Personalized treatments, like autologous cell therapies, are based… Continue reading Whitepaper: Revolutionizing Cell & Gene Therapy Orchestration through the use of a Point-of-Care Manufacturing Model
Munich (DE) – Cell & gene therapies (CGT) is here to revolutionize modern healthcare offering unique opportunities to develop new therapeutic approaches to treat and potentially cure myriad diseases. But the end-to-end coordination of supply chain management for those type of therapies – personalized therapies – is hence complex and poses many challenges. To… Continue reading Orchestration for Cell & Gene Therapies in a Nutshell
Leiden (NL) / Munich (DE) – November 2021 – CellPoint and Hypertrust Patient Data Care (HPDC) today announced the launch of xCellit. The xCellit system was co-developed to make autologous cell therapies available more rapidly and efficiently by facilitating the scheduling, monitoring and data capturing of cell treatment workflows. It is based on HPDC’s X-Chain… Continue reading CellPoint and Hypertrust Patient Data Care co-develop xCellit platform for cell therapies at the point-of-care
© 2024 Hypertrust Patient Data Care, Part of Accenture
